Literature DB >> 29182161

Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting.

Alberto Puccini1, Heinz-Josef Lenz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29182161      PMCID： PMC7491976          DOI： 10.1038/nrclinonc.2017.185

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

Authors:  Michael J Overman; Ray McDermott; Joseph L Leach; Sara Lonardi; Heinz-Josef Lenz; Michael A Morse; Jayesh Desai; Andrew Hill; Michael Axelson; Rebecca A Moss; Monica V Goldberg; Z Alexander Cao; Jean-Marie Ledeine; Gregory A Maglinte; Scott Kopetz; Thierry André
Journal:  Lancet Oncol       Date:  2017-07-19       Impact factor: 41.316

2.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Authors:  Dung T Le; Jennifer N Durham; Kellie N Smith; Hao Wang; Bjarne R Bartlett; Laveet K Aulakh; Steve Lu; Holly Kemberling; Cara Wilt; Brandon S Luber; Fay Wong; Nilofer S Azad; Agnieszka A Rucki; Dan Laheru; Ross Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Tim F Greten; Austin G Duffy; Kristen K Ciombor; Aleksandra D Eyring; Bao H Lam; Andrew Joe; S Peter Kang; Matthias Holdhoff; Ludmila Danilova; Leslie Cope; Christian Meyer; Shibin Zhou; Richard M Goldberg; Deborah K Armstrong; Katherine M Bever; Amanda N Fader; Janis Taube; Franck Housseau; David Spetzler; Nianqing Xiao; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; James R Eshleman; Bert Vogelstein; Robert A Anders; Luis A Diaz
Journal:  Science       Date:  2017-06-08       Impact factor: 47.728

3.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

4.  Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer.

Authors:  Mayada A Aljehani; John W Morgan; Laurel A Guthrie; Brice Jabo; Majed Ramadan; Khaled Bahjri; Sharon S Lum; Matthew Selleck; Mark E Reeves; Carlos Garberoglio; Maheswari Senthil
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

5.  Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.

Authors:  D Arnold; B Lueza; J-Y Douillard; M Peeters; H-J Lenz; A Venook; V Heinemann; E Van Cutsem; J-P Pignon; J Tabernero; A Cervantes; F Ciardiello
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

6.  Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.

Authors:  Sabine Tejpar; Sebastian Stintzing; Fortunato Ciardiello; Josep Tabernero; Eric Van Cutsem; Frank Beier; Regina Esser; Heinz-Josef Lenz; Volker Heinemann
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777

7.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440
  7 in total
  15 in total

1.  Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Authors:  Martin Pichler; Cristian Rodriguez-Aguayo; Su Youn Nam; Mihnea Paul Dragomir; Recep Bayraktar; Simone Anfossi; Erik Knutsen; Cristina Ivan; Enrique Fuentes-Mattei; Sang Kil Lee; Hui Ling; Tina Catela Ivkovic; Guoliang Huang; Li Huang; Yoshinaga Okugawa; Hiroyuki Katayama; Ayumu Taguchi; Emine Bayraktar; Rajat Bhattacharya; Paola Amero; William Ruixian He; Anh M Tran; Petra Vychytilova-Faltejskova; Christiane Klec; Diana L Bonilla; Xinna Zhang; Sanja Kapitanovic; Bozo Loncar; Roberta Gafà; Zhihui Wang; Vittorio Cristini; Samir M Hanash; Menashe Bar-Eli; Giovanni Lanza; Ondrej Slaby; Ajay Goel; Isidore Rigoutsos; Gabriel Lopez-Berestein; George Adrian Calin
Journal:  Gut       Date:  2020-01-27       Impact factor: 23.059

Review 2.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

3.  Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials.

Authors:  Nibras Ahmed; Yasaswi Vengalasetti; Alyson Haslam; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.

Authors:  Shuchen Chang; Guangli Sun; Dan Zhang; Qing Li; Haihua Qian
Journal:  Cell Death Dis       Date:  2020-07-27       Impact factor: 8.469

5.  Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.

Authors:  Takashi Aizawa; Hideaki Karasawa; Ryo Funayama; Matsuyuki Shirota; Takashi Suzuki; Shimpei Maeda; Hideyuki Suzuki; Akihiro Yamamura; Takeshi Naitoh; Keiko Nakayama; Michiaki Unno
Journal:  Cancer Med       Date:  2019-08-29       Impact factor: 4.452

6.  Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro.

Authors:  Yong-Qiang Hou; Ying-Ying Wang; Xing-Can Wang; Yao Liu; Chun-Ze Zhang; Zhe-Sheng Chen; Zhe Zhang; Wei Wang; De-Xin Kong
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-10

7.  CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway.

Authors:  Biyin Chen; Li Song; Xiuzhen Nie; Fangfeng Lin; Zongyang Yu; Wencui Kong; Xiaoyan Qi; Wenwu Wang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

8.  LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit.

Authors:  Senlin Zhao; Bingjie Guan; Yushuai Mi; Debing Shi; Ping Wei; Yanzi Gu; Sanjun Cai; Ye Xu; Xinxiang Li; Dongwang Yan; Mingzhu Huang; Dawei Li
Journal:  Oncogene       Date:  2021-06-18       Impact factor: 9.867

9.  Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.

Authors:  Wen Peng; Jie Li; Ranran Chen; Qiou Gu; Peng Yang; Wenwei Qian; Dongjian Ji; Qingyuan Wang; Zhiyuan Zhang; Junwei Tang; Yueming Sun
Journal:  J Exp Clin Cancer Res       Date:  2019-09-06

10.  Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.

Authors:  Zhexu Dong; Lei Dai; Yong Zhang; Chao Fang; Gang Shi; Ye Chen; Junshu Li; Qin Wang; Jiamei Fu; Yan Yu; Wenshuang Wang; Lin Cheng; Yi Liu; Yi Lin; Yuan Wang; Qingnan Wang; Huiling Wang; Hantao Zhang; Yujing Zhang; Xiaolan Su; Shuang Zhang; Feng Wang; Meng Qiu; Zongguang Zhou; Hongxin Deng
Journal:  PLoS Genet       Date:  2020-11-11       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.